Who Should Receive ACEi or ARB Therapy
{"Image DocumentName": "Who Should Receive ACEi or ARB Therapy?", "Image ImageDescription": "2013. Who Should Receive ACEi or ARB Therapy? \u226555 years of age or. Macrovascular disease or. Microvascular disease. At doses that have shown vascular protection (ramipril 10 mg daily, perindopril 8 mg daily, telmisartan 80 mg daily) Among women with childbearing potential, ACEi or ARB should only be used in the presence of proper preconception counseling & reliable contraception. Stop ACEi or ARB either prior to conception or immediately upon detection of pregnancy.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}